The pharmacokinetic–pharmacodynamic model of telmisartan and hydrochlorothiazide on blood pressure and plasma potassium after long‐term administration in spontaneously hypertensive rats

By  

Fundamental & Clinical Pharmacology, Vol. 29, Iss. 6, 2015-12 ,pp. : 543-552

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biomarkers, Validation and Pharmacokinetic-Pharmacodynamic Modelling

By Colburn W.A.  

Clinical Pharmacokinetics, Vol. 42, Iss. 12, 2003-01 ,pp. : 997-1022

Adis International

Access to resources Recommend Favorite

Pharmacokinetic/Pharmacodynamic Modelling in Diabetes Mellitus

By Landersdorfer Cornelia B.   Jusko William J.  

Clinical Pharmacokinetics, Vol. 47, Iss. 7, 2008-01 ,pp. : 417-448

Adis International

Access to resources Recommend Favorite

Methodological Issues in Pharmacokinetic-Pharmacodynamic Modelling

By Bellissant E.  

Clinical Pharmacokinetics, Vol. 35, Iss. 2, 1998-08 ,pp. : 151-166

Adis International

Access to resources Recommend Favorite

Pharmacokinetic-pharmacodynamic modelling of tiagabine CNS effects upon chronic treatment in rats: lack of change in concentration-EEG effect relationship

By Cleton A.   Altorf B.A.   Voskuyl R.A.   Danhof M.  

European Journal of Pharmaceutical Sciences, Vol. 12, Iss. 2, 2000-12 ,pp. : 141-150

Elsevier

Access to resources Recommend Favorite